Filing Details
- Accession Number:
- 0001209191-14-021116
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-17 19:07:28
- Reporting Period:
- 2014-03-13
- Filing Date:
- 2014-03-17
- Accepted Time:
- 2014-03-17 19:07:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1142596 | Nuvasive Inc | NUVA | Surgical & Medical Instruments & Apparatus (3841) | 330768598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1242610 | M Eileen More | 7475 Lusk Blvd. San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-03-13 | 24,000 | $25.89 | 40,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-03-11 | 24,000 | $37.14 | 16,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right-to-Buy) | Disposition | 2014-03-13 | 24,000 | $0.00 | 24,000 | $25.89 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2011-06-06 | 2017-06-06 | No | 4 | M | Direct |
Footnotes
- Contemporaneous sale of shares aquired upon the cashless exercise of a stock option at an exercise price of $25.89 per share.
- Weighted average from 39 transactions with prices ranging from $37.000 to $37.298. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.